This position supports the findings of fundamental research using a mouse model that demonstrated the existence of mutant cancer antigen-specific T cells, as well as reactivation of these cells by anti-PD-1 antibodies and anti-CTLA-4 antibodies (CTLA-4 is a receptor for the same immunosuppressive signals as PD-1) [80]. This evidence concerns the gene CTLA4 and cancer.